Stocklytics Platform
Asset logo for symbol PRCT
PROCEPT BioRobotics Corporation
PRCT57
$70.76arrow_drop_up1.43%$1.00
Asset logo for symbol PRCT
PRCT57

$70.76

arrow_drop_up1.43%

Income Statement (PRCT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
EBIT-$27.64M-$29.55M-$26.66M-$25.62M-$28.37M
EBITDA-$26.46M-$28.23M-$25.60M-$24.32M-$27.59M
gross Profit$25.03M$19.93M$18.87M$18.42M$12.49M
NET Income-$25.95M-$27.50M-$24.62M-$25.28M-$27.70M
total Revenue$44.53M$43.58M$35.10M$33.10M$24.40M

Balance Sheet (PRCT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt-$144.18M-$178.01M-$207.34M-$68.92M-$100.95M
stockholders Equity$264.04M$280.75M$299.35M$155.90M$173.12M
total Assets$382.90M$404.71M$421.12M$272.44M$284.45M
total Debt$81.38M$79.20M$79.73M$80.76M$80.02M
total Liabilities$118.85M$123.96M$121.76M$116.54M$111.33M

Cash Flow (PRCT)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow$2.58M$2.86M$162.11M$2.43M$380.00K
free Cash Flow-$34.23M-$33.50M-$24.72M-$33.71M-$41.26M
investing Cash Flow----$5.37M-$5.33M
operating Cash Flow-$32.28M-$24.79M-$18.94M-$28.33M-$35.92M

PROCEPT BioRobotics Corporation (PRCT) Financials

The income statement for PROCEPT BioRobotics Corporation (PRCT) provides a snapshot of the company's financial performance over a specific period. It shows the revenue generated by the company, as well as the costs and expenses incurred to generate that revenue. The income statement also includes the company's gross profit, which is the revenue minus the cost of goods sold. Additionally, it provides information on the company's operating expenses and net income from stockholders, which is the profit after subtracting all expenses, taxes, and interest.

Earnings before interest and taxes (EBIT) is a measure of a company's profitability that shows the profit generated from its operations before deducting interest and taxes. It is calculated by subtracting the company's operating expenses from its gross profit. Earnings before interest, taxes, depreciation, and amortization (EBITDA) is a similar metric, but it also takes into account the depreciation and amortization expenses. These metrics provide insight into the company's ability to generate profits from its core operations without considering external factors such as interest and taxes.

The balance sheet for PROCEPT BioRobotics Corporation (PRCT) provides a snapshot of the company's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. The assets include cash equivalents, which are highly liquid assets that can be converted into cash quickly. The liabilities include the company's total debt, which represents the amount of money it owes to creditors. The stockholders' equity represents the shareholders' ownership in the company, which is the difference between the company's assets and liabilities. The balance sheet provides valuable information about the company's financial health and its ability to meet its obligations.

Cash flow is a crucial aspect of any company's financial health. PROCEPT BioRobotics Corporation (PRCT) generates cash through its operations, investments, and financing activities. Operating cash flow represents the cash generated from the company's core operations, such as revenue from sales and payment of expenses. Investing cash flow represents the cash used for purchasing new assets or investments. Financing cash flow includes the cash generated from or used for raising capital, such as issuing or repurchasing stock, taking loans, or paying dividends.

Free cash flow is an important metric that shows the amount of cash a company has left after paying for its operating and capital expenses. It is calculated by subtracting the company's capital expenditures from its operating cash flow. This represents the cash available for the company to invest in new projects, pay down debt, or distribute to shareholders. PROCEPT BioRobotics Corporation (PRCT) also has net debt, which is the difference between its total debt and its cash equivalents. Net debt is an indicator of the company's overall financial leverage and its ability to handle its debt obligations.

add PROCEPT BioRobotics Corporation to watchlist

Keep an eye on PROCEPT BioRobotics Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level